# Assembly Biosciences, Inc. (ASMB)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ASMB/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 21.59M | $ -12.94M | $ -37.60M | N/A | $ 305.65M |
| 2025 | $ 74.03M | $ -6.27M | $ -42.14M | $ 2.63M | $ 206.75M |
| 2024 | $ 29.98M | $ -42.23M | $ -53.76M | $ 3.09M | $ 33.36M |
| 2023 | $ 7.75M | $ -66.20M | $ 24.32M | $ 2.34M | $ 41.10M |
| 2022 | $ 0 | $ -103.99M | $ -94.47M | $ 3.47M | $ 82.66M |
| 2021 | $ 7.43M | $ -154.35M | $ -114.70M | $ 6.48M | $ 168.93M |
| 2020 | $ 100.77M | $ -79.18M | $ -83.03M | $ 10.13M | $ 240.58M |
| 2019 | $ 20.60M | $ -126.02M | $ -110.52M | $ 12.27M | $ 273.22M |
| 2018 | $ 19.55M | $ -119.85M | $ -86.24M | $ 0 | $ 210.65M |
| 2017 | $ 12.15M | $ -57.67M | $ 1.34M | $ 0 | $ 113.12M |
| 2016 | $ 0 | $ -60.90M | $ -48.19M | $ 0 | $ 79.88M |
| 2015 | $ 0 | $ -39.95M | $ -26.33M | $ 0 | $ 118.74M |
| 2014 | $ 0 | $ -33.61M | $ -21.37M | $ 0 | $ 58.57M |
| 2013 | $ 0 | $ -27.60M | $ -25.32M | $ 0 | $ 24.49M |
| 2012 | $ 0 | $ -35.79M | $ -30.87M | $ 0 | $ 17.81M |
| 2011 | $ 0 | $ -50.46M | $ -36.83M | $ 0 | $ 34.53M |
| 2010 | $ -24.83B | $ -23.15M | $ -7.90M | $ 2.49M | $ 11.63M |
| 2009 | $ 0 | $ -6.87M | $ -5.28M | $ 9.01M | $ -13.36M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | 0.08 |
| Current Ratio | 13.99 |

## Other views

- [Metrics](https://sponda.capital/en/ASMB.md)
- [Charts](https://sponda.capital/en/ASMB/charts.md)
- [Compare](https://sponda.capital/en/ASMB/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.